Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
JCO Precision Oncology|January 20, 2022
Precision Prevention: The Current State and Future of Genomically Guided Cancer PreventionNawal Kassem, Leigh Anne Stout, Cynthia Hunter, et al.The Oncologist|August 6, 2017
Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid CancerRevathi Kollipara, Bryan Schneider, Milan Radovich, et al.Nature Reviews. Cancer|October 13, 2006
Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinantsVered Stearns, Bryan Schneider, N Lynn Henry, et al.Journal of Translational Medicine|May 31, 2011
A large, consistent plasma proteomics data set from prospectively collected breast cancer patient and healthy volunteer samplesCatherine P Riley, Xiang Zhang, Harikrishna Nakshatri, et al.Proteomics. Clinical Applications|December 8, 2010
Intrinsic subtype-associated changes in the plasma proteome in breast cancerHarikrishna Nakshatri, Guihong Qi, Jinsam You, et al.Journal of General Internal Medicine|September 1, 2012
Paced respiration for vasomotor and other menopausal symptoms: a randomized, controlled trialJanet S Carpenter, Debra S Burns, Jingwei Wu, et al.Cancer Chemotherapy and Pharmacology|May 31, 2006
A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-alpha2b in patients with solid tumorsBryan Schneider, Anna Fukunaga, Daryl Murry, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2012
A phase I dose-escalation trial of trastuzumab and alvespimycin hydrochloride (KOS-1022; 17 DMAG) in the treatment of advanced solid tumorsKomal Jhaveri, Kathy Miller, Lee Rosen, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 27, 2023
Identification of a SNP cluster associated with taxane-induced peripheral neuropathy risk in patients being treated for breast cancer using GWAS data derived from a large cooperative group trialMaryam Lustberg, Xuan Wu, Juan Luis Fernández-Martínez, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 22, 2023
Leveraging GWAS data derived from a large cooperative group trial to assess the risk of taxane-induced peripheral neuropathy (TIPN) in patients being treated for breast cancer: Part 2-functional implications of a SNP cluster associated with TIPN risk in patients being treated for breast cancerMaryam Lustberg, Xuan Wu, Juan Luis Fernández-Martínez, et al.Pageof 4